a developer of embryonic stem cells for drug discovery and development
Industry Biotechnology
A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with NTLA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To VTGN | 1D Price Change % | ||
---|---|---|---|---|
VTGN | 100% | -3.75% | ||
NTLA - VTGN | 43% Loosely correlated | -3.24% | ||
KYMR - VTGN | 43% Loosely correlated | -2.74% | ||
BEAM - VTGN | 43% Loosely correlated | -1.57% | ||
RCKT - VTGN | 42% Loosely correlated | -2.25% | ||
CRSP - VTGN | 42% Loosely correlated | -1.85% | ||
More |
Ticker / NAME | Correlation To VTGN | 1D Price Change % |
---|---|---|
VTGN | 100% | -3.75% |
drugs theme (254 stocks) | 41% Loosely correlated | -1.72% |
stem cells theme (21 stocks) | 39% Loosely correlated | -3.58% |
biotechnology theme (238 stocks) | 25% Poorly correlated | -1.80% |